152 related articles for article (PubMed ID: 23639447)
1. Retinal thinning in Gaucher disease patients and carriers: results of a pilot study.
McNeill A; Roberti G; Lascaratos G; Hughes D; Mehta A; Garway-Heath DF; Schapira AH
Mol Genet Metab; 2013 Jun; 109(2):221-3. PubMed ID: 23639447
[TBL] [Abstract][Full Text] [Related]
2. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
McNeill A; Magalhaes J; Shen C; Chau KY; Hughes D; Mehta A; Foltynie T; Cooper JM; Abramov AY; Gegg M; Schapira AH
Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
[TBL] [Abstract][Full Text] [Related]
3. Predicting parkinsonism: new opportunities from Gaucher disease.
Lopez G; Sidransky E
Mol Genet Metab; 2013 Jul; 109(3):235-6. PubMed ID: 23665160
[No Abstract] [Full Text] [Related]
4. Parkinson's disease in patients and obligate carriers of Gaucher disease.
Becker JG; Pastores GM; Di Rocco A; Ferraris M; Graber JJ; Sathe S
Parkinsonism Relat Disord; 2013 Jan; 19(1):129-31. PubMed ID: 22940477
[TBL] [Abstract][Full Text] [Related]
5. Hyposmia and cognitive impairment in Gaucher disease patients and carriers.
McNeill A; Duran R; Proukakis C; Bras J; Hughes D; Mehta A; Hardy J; Wood NW; Schapira AH
Mov Disord; 2012 Apr; 27(4):526-32. PubMed ID: 22344629
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
[TBL] [Abstract][Full Text] [Related]
7. Parkinsonism among Gaucher disease carriers.
Goker-Alpan O; Schiffmann R; LaMarca ME; Nussbaum RL; McInerney-Leo A; Sidransky E
J Med Genet; 2004 Dec; 41(12):937-40. PubMed ID: 15591280
[TBL] [Abstract][Full Text] [Related]
8. Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease.
Weill Y; Zimran A; Zadok D; Wasser LM; Revel-Vilk S; Hanhart J; Dinur T; Arkadir D; Becker-Cohen M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987733
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher disease.
Ribner A; Altarescu G; Zimran A; Elstein D
Mov Disord; 2011 Jun; 26(7):1341-3. PubMed ID: 21469198
[TBL] [Abstract][Full Text] [Related]
10. Ganglion Cell Complex Thinning in Young Gaucher Patients: Relation to Prodromal Parkinsonian Markers.
Tantawy AAG; Adly AAM; Hashem NH; Ebeid WM; Abdeen MS; Salah NY
Mov Disord; 2020 Dec; 35(12):2211-2219. PubMed ID: 32918500
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene.
Duarte AJ; Ribeiro D; Santos R; Moreira L; Bragança J; Amaral O
Stem Cell Res; 2019 Dec; 41():101595. PubMed ID: 31678773
[TBL] [Abstract][Full Text] [Related]
12. Identification of Gaucher disease carriers: glucocerebrosidase antigen and DNA analysis.
Lacerda L; Amaral O; Pinto R; Aerts J; Sá Miranda MC
Biochem Med Metab Biol; 1993 Oct; 50(2):190-6. PubMed ID: 8260196
[TBL] [Abstract][Full Text] [Related]
13. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
Zimran A; Neudorfer O; Elstein D
N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15719452
[No Abstract] [Full Text] [Related]
14. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and attitudes of Parkinson's disease risk in the Gaucher population.
Zaretsky L; Zeid N; Naik H; Alcalay RN; Balwani M
J Genet Couns; 2020 Feb; 29(1):105-111. PubMed ID: 31663662
[TBL] [Abstract][Full Text] [Related]
16. Peripapillary retinal nerve fiber layer thinning in patients with autosomal recessive cone-rod dystrophy.
Pasadhika S; Fishman GA; Allikmets R; Stone EM
Am J Ophthalmol; 2009 Aug; 148(2):260-265.e1. PubMed ID: 19406377
[TBL] [Abstract][Full Text] [Related]
17. Spectral-Domain Optical Coherence Tomography Documentation of Transsynaptic Retinal Degeneration.
Schwartz SG; Pasol J; Lam BL; Flynn HW
Ophthalmic Surg Lasers Imaging Retina; 2016 Aug; 47(8):768-72. PubMed ID: 27548455
[TBL] [Abstract][Full Text] [Related]
18. Prodromal Clinical Markers of Parkinson disease in Gaucher Disease Individuals.
Gatto EM; Etcheverry JL; Sanguinetti A; Cesarini M; Fernandez Escobar N; Drelichman G
Eur Neurol; 2016; 76(1-2):19-21. PubMed ID: 27344356
[TBL] [Abstract][Full Text] [Related]
19. A novel Parkinson's disease risk variant, p. W378R, in the Gaucher's disease GBA gene.
Lubomski M; Hayes M; Kennerson M; Ellis M; Chu S; Blackie J; O'Sullivan JD; Nicholson G
Mov Disord; 2018 Oct; 33(10):1662-1664. PubMed ID: 30216542
[No Abstract] [Full Text] [Related]
20. Spectral-Domain Optical Coherence Tomography for Determination of Retinal Thickness in Pediatric Patients with Mild-To-Moderate Chronic Kidney Disease: A Cross-Sectional Study.
Prakasam RK; Götze A; von Keyserlingk S; Jünemann A; Röhlig M; Stachs O; Fischer DC
Curr Eye Res; 2019 Feb; 44(2):206-211. PubMed ID: 30204490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
